9R1R | pdb_00009r1r

Bottlenose dolphin coronavirus spike glycoprotein


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.65 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

wwPDB Validation 3D Report Full Report

Validation slider image for 9R1R

This is version 1.1 of the entry. See complete history

Literature

Cetacean coronavirus spikes highlight S glycoprotein structural plasticity.

Hulswit, R.J.G.Shamorkina, T.M.van der Lee, J.Rosman, F.Wetzels, L.S.van Kuppeveld, F.J.M.Snijder, J.Bosch, B.J.Hurdiss, D.L.

(2026) PLoS Pathog 22: e1013855-e1013855

  • DOI: https://doi.org/10.1371/journal.ppat.1013855
  • Primary Citation Related Structures: 
    9R1Q, 9R1R

  • PubMed Abstract: 

    Coronaviruses (CoVs) exhibit a remarkable ability for spill-over infections into naive host populations. While much research has focused on the spike (S) glycoproteins of zoonotic alpha- and betacoronaviruses, the S proteins of gamma- and deltacoronaviruses, which predominantly infect avian hosts, remain poorly understood. Here, we present high-resolution cryo-EM structures of S proteins from two distinct gammacoronaviruses (75.7% sequence identity) that atypically infect marine mammals and belong to the Gammacoronavirus delphinapteri species. The cryo-EM reconstructions reveal that the spikes exhibit a unique quaternary architecture that distinguishes them from other coronaviruses. The S protein features a previously unidentified, tripodal quaternary assembly of the S1 subunit, in which S1B domains are presented in an upright position while their putative receptor binding sites are shielded by extended loops from the S1A domain of the same protomers. Additionally, the CeCoV spike proteins have evolved an additional and unique ~200 residue N-terminal domain (S10). S10 lacks homology to known protein sequences but displays structural similarity to members of the cupin protein superfamily. This represents a remarkable case of coronaviral exaptation of a host protein integrated into the S glycoprotein. Moreover, glycoproteomic analyses reveal that CeCoV S proteins are extensively N-glycosylated (>100 N-glycans per trimer), with a notable abundance of high-mannose glycans on S10 and O-glycosylation sites within a mucin-like loop at the trimer apex, all contributing to a dense glycan shield and potentially masking immunogenic epitopes. These findings demonstrate the structural diversity and adaptability of CoV S proteins, including alternative quaternary assemblies, additional domains, and diverse glycosylation strategies, offering new insights into the evolutionary mechanisms that enable coronaviruses to expand their host range and establish infections in novel species.


  • Organizational Affiliation
    • Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.

Macromolecule Content 

  • Total Structure Weight: 492.31 kDa 
  • Atom Count: 31,461 
  • Modeled Residue Count: 3,663 
  • Deposited Residue Count: 4,044 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Spike glycoprotein
A, B, C
1,348Bottlenose dolphin coronavirus HKU22Mutation(s): 0 
UniProt
Find proteins for V5TEW2 (Bottlenose dolphin coronavirus HKU22)
Explore V5TEW2 
Go to UniProtKB:  V5TEW2
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupV5TEW2
Glycosylation
Glycosylation Sites: 31
Sequence Annotations
Expand
Reference Sequence

Oligosaccharides

Help  
Entity ID: 3
MoleculeChains Length2D Diagram GlycosylationD Interactions
2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
AA [auth a],
BA [auth b],
DB [auth 3],
E,
EB [auth 4],
AA [auth a],
BA [auth b],
DB [auth 3],
E,
EB [auth 4],
F,
G,
GB [auth 6],
H,
HB [auth 7],
I,
KA [auth k],
LA [auth l],
NA [auth n],
OA [auth o],
QA [auth q],
R,
RA [auth r],
S,
SA [auth s],
TA [auth t],
U,
UA [auth u],
V,
X,
Y,
Z
2N-Glycosylation
Glycosylation Resources
GlyTouCan: G42666HT
GlyCosmos: G42666HT
GlyGen: G42666HT
Entity ID: 4
MoleculeChains Length2D Diagram GlycosylationD Interactions
alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
CB [auth 2],
DA [auth d],
JA [auth j],
K,
Q,
CB [auth 2],
DA [auth d],
JA [auth j],
K,
Q,
WA [auth w]
4N-Glycosylation
Glycosylation Resources
GlyTouCan: G22573RC
GlyCosmos: G22573RC
GlyGen: G22573RC
Entity ID: 5
MoleculeChains Length2D Diagram GlycosylationD Interactions
alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranoseBB [auth 1],
IA [auth i],
P
5N-Glycosylation
Glycosylation Resources
GlyTouCan: G22768VO
GlyCosmos: G22768VO
GlyGen: G22768VO
Entity ID: 6
MoleculeChains Length2D Diagram GlycosylationD Interactions
alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranoseFB [auth 5],
MA [auth m],
T
6N-Glycosylation
Glycosylation Resources
GlyTouCan: G82348BZ
GlyCosmos: G82348BZ
GlyGen: G82348BZ

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
NAG

Query on NAG



Download:Ideal Coordinates CCD File
AC [auth B]
BC [auth B]
CC [auth B]
DC [auth B]
EC [auth B]
AC [auth B],
BC [auth B],
CC [auth B],
DC [auth B],
EC [auth B],
FC [auth B],
GC [auth C],
HC [auth C],
IB [auth A],
IC [auth C],
JB [auth A],
JC [auth C],
KB [auth A],
KC [auth C],
LB [auth A],
LC [auth C],
MB [auth A],
MC [auth C],
NB [auth A],
NC [auth C],
OB [auth A],
OC [auth C],
PB [auth A],
PC [auth C],
QB [auth A],
QC [auth C],
RB [auth A],
RC [auth C],
SB [auth A],
TB [auth A],
UB [auth B],
VB [auth B],
WB [auth B],
XB [auth B],
YB [auth B],
ZB [auth B]
2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N

Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.65 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 
EM Software:
TaskSoftware PackageVersion
MODEL REFINEMENTPHENIX1.21.1_5286

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Innovative Medicines InitiativeSwitzerland101005077

Revision History  (Full details and data files)

  • Version 1.0: 2026-01-14
    Type: Initial release
  • Version 1.1: 2026-08-05
    Changes: Data collection, Database references